Bills would cap insulin cost, mandate cancer screenings

Insulin costs would be capped, and health insurance policies would have to cover more screenings for breast and colorectal cancer, under proposals being considered in the Nebraska Legislature, reports Nebraska Public Media. Included in the package of bills are proposals by Sen. Elliot Bostar to cap insulin costs at $35 for a 30-day supply, and to require state-regulated insurance policies to cover screening for breast cancer. The bill specifies coverage of more frequent screening for women deemed at high risk by national guidelines.